Ligand Pharmaceuticals
NASDAQ: LGNDLa Jolla, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
MW
MATTHEW W. FOEHRDirector
JL
JOHN L. HIGGINSExecutive Officer, Director
JL
JOHN LAMATTINADirector
TD
TODD DAVISDirector
SP
SUNIL PATELDirector
JK
JOHN KOZARICHDirector
MK
MATTHEW KORENBERGDirector
DM
DAVID M. KNOTTDirector
JA
JASON ARYEHDirector
CS
CHARLES S. BERKMANDirector
SS
STEPHEN SABBADirector
MH
MELANIE HERMANDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$85.4MraisedJan 2016 · 22 investors · PharmaceuticalsRule 506(c)
▶$85.4MraisedJan 2016 · 22 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- MATTHEW W. FOEHRDirector
- JOHN L. HIGGINSExecutive Officer, Director
- JOHN LAMATTINADirector
- TODD DAVISDirector
- SUNIL PATELDirector
- JOHN KOZARICHDirector
- MATTHEW KORENBERGDirector
- DAVID M. KNOTTDirector
- JASON ARYEHDirector
- CHARLES S. BERKMANDirector
- STEPHEN SABBADirector
- MELANIE HERMANDirector
- Offering amount
- $85.4M
- Amount sold
- $85.4M
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.